SCHEMBL6966417

SCHEMBL6966417

O=C(O)N1C(=O)OCC1c1ccc(F)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 2/20 0.39
POLQ O75417 2/20 0.35
SLC2A1 P11166 1/20 0.35
RPA1 P27694 1/20 0.35
SLC6A2 P23975 2/20 0.34
IDO1 P14902 1/20 0.34
HTR7 P34969 1/20 0.34
ABCC9 O60706 1/20 0.34
ABCC8 Q09428 1/20 0.34
KCNJ11 Q14654 1/20 0.34
KCNJ8 Q15842 1/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 1/20 0.34
CYP2D6 P10635 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
KCNH2 Q12809 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6082708 0.88 MTOR (0.37) MTORHTR7ALDH1A1HPGDGAA
SCHEMBL6227914 0.88 MTOR (0.37) MTORHTR7ALDH1A1HPGDGAA
SCHEMBL5660885 0.88 MTOR (0.37) MTORHTR7ALDH1A1HPGDGAA
SCHEMBL6904402 0.80 MTOR (0.40) MTORPOLQSLC6A2IDO1HTR7
SCHEMBL8005453 0.79 ALDH1A1 (0.32) ALDH1A1HPGDGAAHTT
SCHEMBL5660976 0.79 ALDH1A1 (0.32) ALDH1A1HPGDGAAHTT
SCHEMBL10308852 0.79 TP53 (0.43) MTORPOLQSLC6A2HTR7ABCC9
SCHEMBL5659497 0.77 RIPK1 (0.37) HTR7ALDH1A1HPGDGAAHTT
SCHEMBL6961509 0.77 RIPK1 (0.37) HTR7ALDH1A1HPGDGAAHTT
SCHEMBL6967561 0.77 FAAH (0.40) ALDH1A1MAPTCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6620815-B1 Selective antagonists for human alpha 1A receptors; benign prostatic hyperplasia, impotency, cardiac arrhythmia treatment; anticholesterol agents; intraocular pressure reduction SYNAPTIC PHARMACEUTICAL CORPORATION 2003-09-16 US disclosed
EP-0988295-A4 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMA CORP (US) 2003-08-13 EP disclosed
US-6159990-A Oxazolidinones as α1A receptor antagonists SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-12-12 US disclosed
EP-0988295-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-03-29 EP disclosed
WO-1998057940-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1998-12-23 WO disclosed